The Alex Manfull Fund
The Alex Manfull Fund (TAMF) is a 501(c)(3) non-profit founded in 2018 that advances awareness, clinician education, and research into post-infectious neuroimmune disorders (PANDAS, PANS, Autoimmune Encephalitis), with an emphasis on adolescents and young adults, through the POND Brain Bank at Georgetown, biennial symposiums, and donor-funded community advocacy.
- Company typePrivate
- Founded2018
- HeadquartersPortsmouth, United States
- Headcount11–50
- GTM typeB2C
- OfferingServices
What The Alex Manfull Fund does
The Alex Manfull Fund (TAMF) is a 501(c)(3) non-profit organization established in 2018 and headquartered in New Castle, New Hampshire, by Susan and Bill "Towny" Manfull following the death of their 26-year-old daughter Alex from PANDAS. The fund's mission is to advance awareness, clinician education, and research into post-infectious neuroimmune disorders—principally PANDAS, PANS, and Autoimmune Encephalitis—with an explicit emphasis on adolescents and young adults. Its primary constituents are healthcare practitioners (physicians, psychologists, nurses, mental health professionals, researchers, and policymakers) seeking training on diagnosis and treatment, and families and patients affected by these often-misdiagnosed conditions.
The organization's core scientific asset is the POND (Pediatric Neuroimmune Disorders) Brain Bank at Georgetown University Medical Center, established in collaboration with TAMF and described as the nation's only brain bank dedicated to storing tissue from individuals diagnosed with PANDAS, PANS, and related neuroimmune disorders. The bank conducts neuropathological evaluations and procures, stores, and distributes tissue and biofluids to researchers worldwide for biomarker discovery. Complementary educational infrastructure includes biennial symposiums in Portsmouth, NH (2019, 2022, 2024, with a fourth scheduled for November 14, 2026), the "Untangling PANDAS & PANS" podcast, periodic newsletters (Volume 1 launched May 2024), fact sheets (including Spanish translation), video archives, and the À Table Project for community engagement. TAMF also conducts annual Advocacy Day on Capitol Hill for legislative and policy change.
As a non-profit, TAMF generates no product revenue; funding comes entirely from charitable donations, sponsorships, and community fundraising events (including the 36 Hours weekend and 5K Run/Walk, which together raised more than $140,000 in 2024). Strategic financial supporters include the Neuroimmune Foundation, Minerva Foundation, George W. Pappas Family Trust, KabaFusion, American Tower, and the Louisa Adelynne Fund for Complex Diseases. Core operational partnerships are with Georgetown University Medical Center (Brain Bank and four-year PANDAS/PANS Fellowship Fund launched October 2024) and Dartmouth Health/Dartmouth Hitchcock Medical Center, whose PING program regularly contributes speakers to TAMF programming. The organization is governed by a Board of Directors assembled in October 2021, supplemented by a Scientific and Medical Advisory Board.
The Alex Manfull Fund firmographics
Firmographics- Name
- The Alex Manfull Fund
- Legal name
- The Alex Manfull Fund
- Website
- https://thealexmanfullfund.org
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- The Alex Manfull Fund (TAMF) is a 501(c)(3) non-profit founded in 2018 that advances awareness, clinician education, and research into post-infectious neuroimmune disorders (PANDAS, PANS, Autoimmune Encephalitis), with an emphasis on adolescents and young adults, through the POND Brain Bank at Georgetown, biennial symposiums, and donor-funded community advocacy.
- Ownership category
- akta.pro rank
The Alex Manfull Fund industry classification
Industry- Product category
- Nonprofit Health Advocacy
- NAICS
- Voluntary Health Organizations (813212), Grantmaking Foundations (813211)
- SIC
- Services-Health Services (8000)
- akta.pro industry
- Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS)Health & Medical Research Grantmaking FoundationsPrivate Foundations
Keywords
Where The Alex Manfull Fund is headquartered
LocationHeadquarters
- HQ city
- Portsmouth
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
The Alex Manfull Fund business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- Charitable Donations: The Alex Manfull Fund operates as a 501(c)(3) non-profit organization that raises funds through donations from individuals, foundations, and corporations. The fund received transformational gifts from various donors and supporters in 2024, raising more than $140,000 from a single weekend event.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels7 records
The Alex Manfull Fund product offering
Product offeringCore offering
The Alex Manfull Fund is a 501(c)(3) non-profit organization that supports awareness, education, and research to further understand post-infectious neuroimmune disorders (PANDAS, PANS, and Autoimmune Encephalitis) with emphasis on adolescents and young adults. Its core offerings include biennial medical symposiums for clinicians, the POND Brain Bank at Georgetown University Medical Center, a podcast, newsletters, fact sheets, community fundraising events, and legislative advocacy including Capitol Hill Advocacy Day.
Product overview
The Alex Manfull Fund is a 501(c)(3) non-profit organization that operates as an awareness, education, and research support organization rather than a traditional technology product company. The organization's core offerings include educational content products (podcasts, newsletters, videos, fact sheets), biennial symposiums for medical professionals, and research support through the POND Brain Bank at Georgetown University. The TAMF Podcast – Untangling PANDAS & PANS, TAMF Newsletters, and educational videos serve as the primary content-based products, while the organization's symposiums and the POND Brain Bank represent its research and professional education initiatives.
Differentiator
Problem solved
Functional benefit
Products and services
- PANDAS/PANS Symposium Biennial educational symposiums held in Portsmouth, NH for physicians, psychologists, nurses, mental health professionals, researchers, and policymakers, featuring the latest research and clinical practice information on neuroimmune psychiatric disorders. Past events held in 2019, 2022, and 2024, with the next scheduled for November 14, 2026 under the theme 'ONE BODY'. Attendance is limited to medical and research professionals.
Quantifiable outcome
- The fund has established the only POND Brain Bank in the nation dedicated to PANDAS/PANS research
- +1 more outcomes
Companies that use The Alex Manfull Fund
Customer profileSegments2 records
Ideal customer profiles3 records
The Alex Manfull Fund technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
The Alex Manfull Fund partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- Georgetown University Medical Center (GUMC)coreThe Alex Manfull Fund collaborated with Georgetown University Medical Center to establish the POND Brain Bank, the nation's only brain bank dedicated to storing brains from individuals diagnosed with PANDAS, PANS, and other neuroimmune disorders. The fund also partnered with GUMC to establish The Alex Manfull PANDAS/PANS Fellowship Fund, a four-year initiative to educate neuroimmunology fellows on pediatric autoimmune neuropsychiatric disorders.
- Georgetown University Medical Center - POND Brain BankcoreThe POND Brain Bank provides detailed neuropathological evaluations and oversees the procurement, storage, and distribution of tissue and biofluids to researchers worldwide to discover biomarkers for PANDAS and PANS. Alex Manfull's brain was donated to establish this resource.
- Dartmouth Health / Dartmouth Hitchcock Medical CentercoreDartmouth Health is a leader in research and treatment of PANDAS/PANS and has established a PING (Psychiatry Immunology and Neurology Group) program. Multiple speakers from Dartmouth present at TAMF symposiums, including Dr. Juliette Madan and Dr. Richard Morse.
Scale indicators2 records
Recent moves7 records
Expansion highlights5 records
The Alex Manfull Fund competitors and assessment
Company assessmentBroad incumbents
- National Organization for Rare Disorders (NORD): Umbrella advocacy organization for rare diseases, including PANDAS/PANS; offers broader policy, research-grant, and patient-navigation infrastructure that TAMF taps into rather than competes with directly.
- Autoimmune Encephalitis Alliance: Established nonprofit supporting patients with autoimmune encephalitis — a sibling neuroimmune condition explicitly named in TAMF's mission; broader disease portfolio and longer operating history.
- International OCD Foundation: National nonprofit for obsessive-compulsive disorder, a frequent misdiagnosis destination for PANDAS/PANS patients; targets overlapping clinician and family audiences at much larger scale.
Others
- Georgetown University Medical Center: TAMF's core academic partner that houses the POND Brain Bank and runs the PANDAS/PANS Fellowship Fund; institutionally adjacent but not a fundraising competitor.
- Children's Hospital of Philadelphia (CHOP) - PANDAS/PANS Research Program: Major pediatric academic medical center running PANDAS/PANS clinical care and research programs; indirectly comparable as a research-and-care ecosystem stakeholder rather than a competing nonprofit.
- Brain & Behavior Research Foundation: Major U.S. nonprofit funding grants for psychiatric and neuroscience research, including areas adjacent to PANS/PANDAS; an enabler/funder peer rather than a direct competitor.
Direct peers
- PANDAS Network: Nonprofit focused on PANDAS/PANS awareness, education, and research support; mirrors TAMF's mission almost exactly and competes for the same donor and clinician audiences.
- Neuroimmune Foundation: Disease-specific nonprofit promoting understanding of PANS/PANDAS and related conditions; listed as a TAMF transformational-gift supporter and competes for the same mission-aligned donor base.
- ASPIRE (Alliance to Solve PANS, Immune-Related Encephalopathies): PANS-specific advocacy and clinician-education nonprofit that runs conferences, CME courses, and resource directories targeting the same healthcare practitioner audience TAMF serves.
Emerging players
- Moleculera Labs: Commercial clinical lab offering the Cunningham Panel of autoantibody tests used in evaluating PANS/PANDAS; complements TAMF's awareness and research mission but operates in the adjacent diagnostic-services layer.
Market position
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
The Alex Manfull Fund social profiles
Digital presenceThe Alex Manfull Fund financial estimates
Financial estimateRevenue estimate
Valuation estimate
The Alex Manfull Fund leadership team
Management profileNumber of profiles
Profiles4 records
The Alex Manfull Fund funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
The Alex Manfull Fund M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about The Alex Manfull Fund
What does The Alex Manfull Fund do?
The Alex Manfull Fund is a 501(c)(3) non-profit organization that supports awareness, education, and research to further understand post-infectious neuroimmune disorders (PANDAS, PANS, and Autoimmune Encephalitis) with emphasis on adolescents and young adults. Its core offerings include biennial medical symposiums for clinicians, the POND Brain Bank at Georgetown University Medical Center, a podcast, newsletters, fact sheets, community fundraising events, and legislative advocacy including Capitol Hill Advocacy Day.
Is The Alex Manfull Fund a public or private company?
The Alex Manfull Fund is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was The Alex Manfull Fund founded?
The Alex Manfull Fund was founded in 2018. It employs 11 to 50 people.
Where is The Alex Manfull Fund based?
The Alex Manfull Fund is headquartered in Portsmouth, United States, in the North America region.
How does The Alex Manfull Fund make money?
One revenue line is on record: charitable Donations.
Who are The Alex Manfull Fund's main competitors?
Broad incumbents on record are National Organization for Rare Disorders (NORD), Autoimmune Encephalitis Alliance and International OCD Foundation. Others are Georgetown University Medical Center, Children's Hospital of Philadelphia (CHOP) - PANDAS/PANS Research Program and Brain & Behavior Research Foundation. Direct peers are PANDAS Network, Neuroimmune Foundation and ASPIRE (Alliance to Solve PANS, Immune-Related Encephalopathies). Moleculera Labs is listed as an emerging player.
Does The Alex Manfull Fund have an API?
No public API is recorded for The Alex Manfull Fund.
What industry is The Alex Manfull Fund in?
The Alex Manfull Fund's product category is Nonprofit Health Advocacy. Its primary akta.pro industry code is BPAGACAA, Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS), with a secondary code of BPAGAKAL, Health & Medical Research Grantmaking Foundations. Its NAICS code is 813212 and its SIC code is 8000.